The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

Business debate on research and innovation (R&I) funding in the EU’s new mandate, global health leaders underlined the ...

The Pan American Health Organization (PAHO) has issued an epidemiological alert regarding the increased risk of dengue ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

Introduction State of the Art Dengue Vaccine Development Challenges in Dengue Vaccine Development Emerging Opportunities for Advancing Dengue Vaccine References State of the Art Dengue Vaccine ...

Three species of mosquito are of particular concern in Europe, according to the European Centre for Disease Prevention and ...

The Pan American Health Organization (PAHO) has issued an epidemiological alert regarding the increased risk of dengue outbreaks in the Americas, attributed to the growing circulation of the DENV-3 ...

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...

Here’s a look at Zika virus, an illness spread through mosquito bites that can cause birth defects and other neurological defects. Facts Sources: Centers for Disease Control and Prevention (CDC), ...

"A safe and effective dengue virus vaccine is clearly the long-term solution, but more immediate strategies are urgently needed to combat the current dengue problem." There is reason to be ...